Nationwide Fund Advisors Has $12.19 Million Holdings in Acadia Healthcare Company, Inc. (ACHC)
Nationwide Fund Advisors boosted its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 225.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 246,842 shares of the company’s stock after purchasing an additional 170,990 shares during the period. Nationwide Fund Advisors owned approximately 0.28% of Acadia Healthcare worth $12,189,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Acadia Healthcare by 11.1% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock worth $134,000 after purchasing an additional 270 shares during the last quarter. Riverhead Capital Management LLC bought a new stake in Acadia Healthcare in the second quarter worth about $209,000. World Asset Management Inc bought a new stake in Acadia Healthcare in the second quarter worth about $242,000. Paloma Partners Management Co bought a new stake in Acadia Healthcare in the first quarter worth about $217,000. Finally, Summit Securities Group LLC bought a new stake in shares of Acadia Healthcare during the second quarter valued at approximately $248,000.
COPYRIGHT VIOLATION NOTICE: “Nationwide Fund Advisors Has $12.19 Million Holdings in Acadia Healthcare Company, Inc. (ACHC)” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/09/24/nationwide-fund-advisors-has-12-19-million-holdings-in-acadia-healthcare-company-inc-achc.html.
Several research firms have recently weighed in on ACHC. Mizuho lifted their price target on shares of Acadia Healthcare from $57.00 to $60.00 and gave the company a “buy” rating in a research note on Friday, July 28th. BidaskClub raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Saturday, June 10th. Craig Hallum reaffirmed a “buy” rating and set a $65.00 price target (up previously from $52.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. UBS AG reaffirmed a “positive” rating and set a $60.00 price target (up previously from $54.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. Finally, Deutsche Bank AG lifted their price target on shares of Acadia Healthcare from $58.00 to $60.00 and gave the company a “buy” rating in a research note on Monday, July 31st. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. Acadia Healthcare currently has an average rating of “Buy” and an average price target of $58.69.
In other Acadia Healthcare news, President Brent Turner sold 206,252 shares of the stock in a transaction that occurred on Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total transaction of $10,454,913.88. Following the sale, the president now directly owns 81,106 shares in the company, valued at approximately $4,111,263.14. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Christopher L. Howard sold 53,713 shares of the stock in a transaction that occurred on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total transaction of $2,722,711.97. Following the sale, the executive vice president now owns 147,286 shares in the company, valued at $7,465,927.34. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 3,135,693 shares of company stock worth $160,231,099. 11.10% of the stock is owned by company insiders.
Acadia Healthcare Company, Inc. (NASDAQ ACHC) opened at 46.02 on Friday. The company has a market cap of $4.04 billion, a P/E ratio of 505.71 and a beta of 1.14. Acadia Healthcare Company, Inc. has a 52 week low of $32.54 and a 52 week high of $54.34. The company has a 50-day moving average of $48.52 and a 200-day moving average of $45.93.
Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Thursday, July 27th. The company reported $0.66 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.01. The firm had revenue of $715.90 million during the quarter, compared to analysts’ expectations of $717.38 million. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The firm’s quarterly revenue was down 5.4% on a year-over-year basis. During the same quarter last year, the company posted $0.73 EPS. On average, equities research analysts predict that Acadia Healthcare Company, Inc. will post $2.45 EPS for the current year.
Acadia Healthcare Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Stock Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related stocks with our FREE daily email newsletter.